The Pfizer candidate is a protease inhibitor that prevents the virus from replicating in cells.Reuters Pfizer has started an early-stage US trial of an oral Covid-19 antiviral therapy that could be prescribed to patients at the first sign of infection, the company said on Tuesday (March 23). The drugmaker, which developed the first authorised Covid-19 vaccine in...
The preliminary data was from Phase I and II clinical trials involving over 500 people.Reuters Sinovac Biotech's Covid-19 vaccine appears to be safe and able to trigger immune responses among children and adolescents, according to preliminary results from early and mid-stage trials, the company said late on Monday (March 22). The preliminary data was from Phase I...
Under the new fund, individuals requiring extended hospitalisation due to a vaccine reaction will be eligible for RM50,000 (S$16,333).Reuters Malaysia on Monday (March 22) announced it had established a RM10 million (S$3.3 million) compensation fund to provide cash assistance for any Covid-19 vaccine recipients who suffer severe reactions due to inoculations. The South-east Asian country has inoculated...
Singapore is closely monitoring ongoing trials on the effect of Covid-19 vaccines on children.The Straits Times file Singapore is closely monitoring ongoing trials on the safety and effectiveness of Covid-19 vaccines on children, and hopes to be able to certify and administer them on students here in the near future. For now, the vaccines that the Government...
YB Khairy Jamaluddin made history this week by becoming the first Malaysian to receive the Sinovac anti-Covid-19 vaccine on Thursday (18th March). One thing that caught the public’s attention, though, would be Khairy’s reaction half an hour after taking the jab. The Minister of Science, Technology and Information jokingly remarked that he has also improved his fluency...
